FBLN2 promoter hypermethylation: a negative prognostic biomarker and anti-PD-1 response predictor in clear cell renal cell carcinoma via high-throughput CpG Island screening

Most Recent Articles: Clinical Epigenetics

By: Wenfeng Liao · Lianzi Yu · Lufang Zhang · Jie Shao · Guanhua Li · Jialei Hua · Shuya Zhao · Li Jia · Yawei Han · Aimin Zhang · Xin Yao · Yueguo Li and Dong Dong

8 October 2025 at 08:00

Clear cell renal cell carcinoma (ccRCC), with rising incidence globally, shows heterogeneous responses to immune checkpoint blockade (ICB). DNA methylation dysregulation impacts tumor immunity, necessitating p...

Reading view